Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
Condition:   Small Cell Lung Cancer Interventions:   Drug: Irinotecan;   Drug: Simvastatin Sponsors:   Shanghai Pulmonary Hospital, Shanghai, China;   Chinese Academy of Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2021 Category: Research Source Type: clinical trials